Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial

Steven E. Nissen, Ricardo E. Dent-Acosta, Robert S. Rosenson, Erik S. Stroes, N. Sattar, David Preiss, G. B John Mancini, Christie M. Ballantyne, A. Catapano, Ioanna Gouni-Berthold, E. A. Stein, Allen Xue, Scott M. Wasserman, R. Scott, P. D. Thompson

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalClinical Cardiology
Volume39
Issue number3
DOIs
Publication statusPublished - 2016

Cite this

Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. / Nissen, Steven E.; Dent-Acosta, Ricardo E.; Rosenson, Robert S.; Stroes, Erik S.; Sattar, N.; Preiss, David; Mancini, G. B John; Ballantyne, Christie M.; Catapano, A.; Gouni-Berthold, Ioanna; Stein, E. A.; Xue, Allen; Wasserman, Scott M.; Scott, R.; Thompson, P. D.

In: Clinical Cardiology, Vol. 39, No. 3, 2016, p. 137-144.

Research output: Contribution to journalArticle

Nissen, SE, Dent-Acosta, RE, Rosenson, RS, Stroes, ES, Sattar, N, Preiss, D, Mancini, GBJ, Ballantyne, CM, Catapano, A, Gouni-Berthold, I, Stein, EA, Xue, A, Wasserman, SM, Scott, R & Thompson, PD 2016, 'Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial', Clinical Cardiology, vol. 39, no. 3, pp. 137-144. https://doi.org/10.1002/clc.22518
Nissen, Steven E. ; Dent-Acosta, Ricardo E. ; Rosenson, Robert S. ; Stroes, Erik S. ; Sattar, N. ; Preiss, David ; Mancini, G. B John ; Ballantyne, Christie M. ; Catapano, A. ; Gouni-Berthold, Ioanna ; Stein, E. A. ; Xue, Allen ; Wasserman, Scott M. ; Scott, R. ; Thompson, P. D. / Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. In: Clinical Cardiology. 2016 ; Vol. 39, No. 3. pp. 137-144.
@article{01fac0a6090540f9b502e39a9172044b,
title = "Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial",
author = "Nissen, {Steven E.} and Dent-Acosta, {Ricardo E.} and Rosenson, {Robert S.} and Stroes, {Erik S.} and N. Sattar and David Preiss and Mancini, {G. B John} and Ballantyne, {Christie M.} and A. Catapano and Ioanna Gouni-Berthold and Stein, {E. A.} and Allen Xue and Wasserman, {Scott M.} and R. Scott and Thompson, {P. D.}",
note = "Cited By :3 Export Date: 5 April 2017",
year = "2016",
doi = "10.1002/clc.22518",
language = "English",
volume = "39",
pages = "137--144",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial

AU - Nissen, Steven E.

AU - Dent-Acosta, Ricardo E.

AU - Rosenson, Robert S.

AU - Stroes, Erik S.

AU - Sattar, N.

AU - Preiss, David

AU - Mancini, G. B John

AU - Ballantyne, Christie M.

AU - Catapano, A.

AU - Gouni-Berthold, Ioanna

AU - Stein, E. A.

AU - Xue, Allen

AU - Wasserman, Scott M.

AU - Scott, R.

AU - Thompson, P. D.

N1 - Cited By :3 Export Date: 5 April 2017

PY - 2016

Y1 - 2016

U2 - 10.1002/clc.22518

DO - 10.1002/clc.22518

M3 - Article

VL - 39

SP - 137

EP - 144

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 3

ER -